US Stock MarketDetailed Quotes

Gyre Therapeutics (GYRE)

Watchlist
  • 7.700
  • +0.010+0.13%
Close Jan 15 16:00 ET
  • 7.850
  • +0.150+1.95%
Post 20:01 ET
699.86MMarket Cap192.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gyre Therapeutics (GYRE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
170.92%4.68M
138.01%2.09M
-104.47%-129K
-114.06%-3.64M
-182.08%-2.76M
-77.24%1.73M
-221.18%-5.49M
-72.31%2.88M
142.50%25.89M
3.36M
Net income from continuing operations
107.84%5.94M
-65.27%1.58M
-62.42%3.73M
120.94%17.9M
100.56%569K
-61.97%2.86M
20.37%4.54M
135.59%9.94M
-2,081.46%-85.48M
---100.98M
Operating gains losses
-86.08%43K
93.12%-192K
48.02%-2.2M
-148.91%-6.83M
-100.92%-118K
-57.08%309K
-2,807.77%-2.79M
-1,332.36%-4.23M
5,371.76%13.95M
--12.79M
Depreciation and amortization
45.84%649K
181.14%641K
28.92%535K
42.55%1.59M
62.34%500K
120.30%445K
-28.30%228K
45.10%415K
-1.33%1.11M
--308K
Deferred tax
---531K
-209.28%-300K
38.98%-191K
13.62%-1M
-46.90%-592K
--0
57.83%-97K
4.57%-313K
-38.42%-1.16M
---403K
Other non cash items
68.88%-61K
17.27%-91K
470.52%641K
-100.74%-613K
-100.16%-134K
-790.91%-196K
-15.79%-110K
-2,262.50%-173K
36,531.42%82.79M
--82.9M
Change In working capital
-27.43%-2.45M
96.09%-289K
-21.36%-3.35M
-310.35%-15.69M
-346.83%-3.62M
-210.48%-1.93M
-1,224.05%-7.39M
-146.31%-2.76M
195.65%7.46M
--1.47M
-Change in receivables
-122.57%-1.19M
20.44%-2.61M
152,000.00%1.52M
-813.13%-9.29M
-305.63%-5.47M
33.83%-536K
-622.03%-3.28M
-99.97%1K
116.44%1.3M
---1.35M
-Change in inventory
111.32%72K
-32.68%-954K
-131.38%-1.54M
-222.44%-2.14M
-164.13%-118K
-169.06%-636K
-714.53%-719K
-226.86%-666K
298.75%1.75M
--184K
-Change in prepaid assets
0.00%398K
928.92%5.45M
-263.58%-5.54M
734.15%520K
306.17%2.3M
6,533.33%398K
-2,956.52%-657K
-124.78%-1.52M
-108.43%-82K
--567K
-Change in payables and accrued expense
-51.83%-1.49M
55.99%-1.9M
485.56%2.19M
-178.78%-3.99M
25.33%1.88M
-51.85%-984K
-488.40%-4.32M
-118.31%-568K
1,006.11%5.07M
--1.5M
-Change in other current liabilities
-41.32%-236K
-118.70%-297K
--25K
-37.91%-793K
-491.86%-2.21M
-87.64%-167K
1,226.24%1.59M
--0
-34.03%-575K
--565K
-Change in other working capital
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
170.92%4.68M
138.01%2.09M
-104.47%-129K
-114.06%-3.64M
-182.08%-2.76M
-77.24%1.73M
-221.18%-5.49M
-72.31%2.88M
142.50%25.89M
--3.36M
Investing cash flow
Cash flow from continuing investing activities
47.76%-1.25M
63.23%-3.04M
127.24%1.97M
-0.63%-19.88M
-249.66%-2M
55.80%-2.39M
-2.76%-8.27M
5.60%-7.22M
-43.04%-19.76M
1.34M
Net PPE purchase and sale
4.30%-668K
80.78%-238K
33.15%-121K
75.63%-1.91M
109.41%203K
56.67%-698K
47.16%-1.24M
89.61%-181K
-57.53%-7.85M
---2.16M
Net intangibles purchase and sale
-400.00%-15K
---23K
---699K
-1,078.26%-813K
-80,900.00%-810K
-50.00%-3K
--0
--0
-430.77%-69K
---1K
Net business purchase and sale
----
----
----
-141.93%-1.69M
--0
----
----
----
401.88%4.02M
--5.02M
Net investment purchase and sale
---564K
60.47%-2.78M
139.59%2.79M
1.68%-15.47M
0.21%-1.4M
--0
-23.27%-7.04M
-20.51%-7.04M
-110.25%-15.74M
---1.4M
Net other investing changes
----
----
----
----
----
----
----
----
---124K
----
Cash from discontinued investing activities
Investing cash flow
47.76%-1.25M
63.23%-3.04M
127.24%1.97M
-0.63%-19.88M
-249.66%-2M
55.80%-2.39M
-2.76%-8.27M
5.60%-7.22M
-43.04%-19.76M
--1.34M
Financing cash flow
Cash flow from continuing financing activities
12.65%365K
14,227.56%22.35M
104.26%1.34M
-15.92%2.1M
-61.44%964K
324K
156K
658K
2.5M
2.5M
Net common stock issuance
--0
--23M
--509K
--773K
--773K
--0
--0
--0
--0
----
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--2.5M
----
Proceeds from stock option exercised by employees
-86.63%50K
275.27%1.03M
45.29%956K
--1.87M
--558K
--374K
--275K
--658K
--0
--0
Net other financing activities
730.00%315K
---1.68M
---121K
---536K
---367K
---50K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
12.65%365K
14,227.56%22.35M
104.26%1.34M
-15.92%2.1M
-61.44%964K
--324K
--156K
--658K
--2.5M
--2.5M
Net cash flow
Beginning cash position
126.69%36.49M
-49.49%15.05M
-64.75%11.81M
33.10%33.51M
-39.16%15.87M
-32.15%16.1M
5.83%29.79M
33.10%33.51M
-16.65%25.18M
--26.08M
Current changes in cash
1,225.82%3.79M
257.22%21.4M
186.51%3.18M
-348.18%-21.42M
-152.76%-3.8M
-115.44%-337K
-286.87%-13.61M
-232.83%-3.68M
375.17%8.63M
--7.2M
Effect of exchange rate changes
10.38%117K
162.82%49K
208.70%50K
8.39%-273K
-210.39%-255K
-38.01%106K
91.33%-78K
-123.00%-46K
84.24%-298K
--231K
End cash Position
154.65%40.4M
126.69%36.49M
-49.49%15.05M
-64.75%11.81M
-64.75%11.81M
-39.16%15.87M
-32.15%16.1M
5.83%29.79M
33.10%33.51M
--33.51M
Free cash flow
287.67%3.99M
126.03%1.81M
-135.81%-950K
-139.11%-6.77M
-438.45%-3.5M
-81.63%1.03M
-438.15%-6.95M
-69.19%2.65M
204.74%17.31M
--1.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 170.92%4.68M138.01%2.09M-104.47%-129K-114.06%-3.64M-182.08%-2.76M-77.24%1.73M-221.18%-5.49M-72.31%2.88M142.50%25.89M3.36M
Net income from continuing operations 107.84%5.94M-65.27%1.58M-62.42%3.73M120.94%17.9M100.56%569K-61.97%2.86M20.37%4.54M135.59%9.94M-2,081.46%-85.48M---100.98M
Operating gains losses -86.08%43K93.12%-192K48.02%-2.2M-148.91%-6.83M-100.92%-118K-57.08%309K-2,807.77%-2.79M-1,332.36%-4.23M5,371.76%13.95M--12.79M
Depreciation and amortization 45.84%649K181.14%641K28.92%535K42.55%1.59M62.34%500K120.30%445K-28.30%228K45.10%415K-1.33%1.11M--308K
Deferred tax ---531K-209.28%-300K38.98%-191K13.62%-1M-46.90%-592K--057.83%-97K4.57%-313K-38.42%-1.16M---403K
Other non cash items 68.88%-61K17.27%-91K470.52%641K-100.74%-613K-100.16%-134K-790.91%-196K-15.79%-110K-2,262.50%-173K36,531.42%82.79M--82.9M
Change In working capital -27.43%-2.45M96.09%-289K-21.36%-3.35M-310.35%-15.69M-346.83%-3.62M-210.48%-1.93M-1,224.05%-7.39M-146.31%-2.76M195.65%7.46M--1.47M
-Change in receivables -122.57%-1.19M20.44%-2.61M152,000.00%1.52M-813.13%-9.29M-305.63%-5.47M33.83%-536K-622.03%-3.28M-99.97%1K116.44%1.3M---1.35M
-Change in inventory 111.32%72K-32.68%-954K-131.38%-1.54M-222.44%-2.14M-164.13%-118K-169.06%-636K-714.53%-719K-226.86%-666K298.75%1.75M--184K
-Change in prepaid assets 0.00%398K928.92%5.45M-263.58%-5.54M734.15%520K306.17%2.3M6,533.33%398K-2,956.52%-657K-124.78%-1.52M-108.43%-82K--567K
-Change in payables and accrued expense -51.83%-1.49M55.99%-1.9M485.56%2.19M-178.78%-3.99M25.33%1.88M-51.85%-984K-488.40%-4.32M-118.31%-568K1,006.11%5.07M--1.5M
-Change in other current liabilities -41.32%-236K-118.70%-297K--25K-37.91%-793K-491.86%-2.21M-87.64%-167K1,226.24%1.59M--0-34.03%-575K--565K
-Change in other working capital --0------------------------------------
Cash from discontinued investing activities
Operating cash flow 170.92%4.68M138.01%2.09M-104.47%-129K-114.06%-3.64M-182.08%-2.76M-77.24%1.73M-221.18%-5.49M-72.31%2.88M142.50%25.89M--3.36M
Investing cash flow
Cash flow from continuing investing activities 47.76%-1.25M63.23%-3.04M127.24%1.97M-0.63%-19.88M-249.66%-2M55.80%-2.39M-2.76%-8.27M5.60%-7.22M-43.04%-19.76M1.34M
Net PPE purchase and sale 4.30%-668K80.78%-238K33.15%-121K75.63%-1.91M109.41%203K56.67%-698K47.16%-1.24M89.61%-181K-57.53%-7.85M---2.16M
Net intangibles purchase and sale -400.00%-15K---23K---699K-1,078.26%-813K-80,900.00%-810K-50.00%-3K--0--0-430.77%-69K---1K
Net business purchase and sale -------------141.93%-1.69M--0------------401.88%4.02M--5.02M
Net investment purchase and sale ---564K60.47%-2.78M139.59%2.79M1.68%-15.47M0.21%-1.4M--0-23.27%-7.04M-20.51%-7.04M-110.25%-15.74M---1.4M
Net other investing changes -----------------------------------124K----
Cash from discontinued investing activities
Investing cash flow 47.76%-1.25M63.23%-3.04M127.24%1.97M-0.63%-19.88M-249.66%-2M55.80%-2.39M-2.76%-8.27M5.60%-7.22M-43.04%-19.76M--1.34M
Financing cash flow
Cash flow from continuing financing activities 12.65%365K14,227.56%22.35M104.26%1.34M-15.92%2.1M-61.44%964K324K156K658K2.5M2.5M
Net common stock issuance --0--23M--509K--773K--773K--0--0--0--0----
Net preferred stock issuance --------------0------------------2.5M----
Proceeds from stock option exercised by employees -86.63%50K275.27%1.03M45.29%956K--1.87M--558K--374K--275K--658K--0--0
Net other financing activities 730.00%315K---1.68M---121K---536K---367K---50K----------------
Cash from discontinued financing activities
Financing cash flow 12.65%365K14,227.56%22.35M104.26%1.34M-15.92%2.1M-61.44%964K--324K--156K--658K--2.5M--2.5M
Net cash flow
Beginning cash position 126.69%36.49M-49.49%15.05M-64.75%11.81M33.10%33.51M-39.16%15.87M-32.15%16.1M5.83%29.79M33.10%33.51M-16.65%25.18M--26.08M
Current changes in cash 1,225.82%3.79M257.22%21.4M186.51%3.18M-348.18%-21.42M-152.76%-3.8M-115.44%-337K-286.87%-13.61M-232.83%-3.68M375.17%8.63M--7.2M
Effect of exchange rate changes 10.38%117K162.82%49K208.70%50K8.39%-273K-210.39%-255K-38.01%106K91.33%-78K-123.00%-46K84.24%-298K--231K
End cash Position 154.65%40.4M126.69%36.49M-49.49%15.05M-64.75%11.81M-64.75%11.81M-39.16%15.87M-32.15%16.1M5.83%29.79M33.10%33.51M--33.51M
Free cash flow 287.67%3.99M126.03%1.81M-135.81%-950K-139.11%-6.77M-438.45%-3.5M-81.63%1.03M-438.15%-6.95M-69.19%2.65M204.74%17.31M--1.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -